Skip to content

evaluation and comparing two different consentrations of bupivacaine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sectionse

evaluation and comparing two different consentrations of bupivacaine in Transversus Abdominis Plane (TAP) Block for Post-operative Analgesia in Patients Undergoing Cesarean Sectionse

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20100102002963N38
Enrollment
60
Registered
2025-04-26
Start date
2025-05-05
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesia by TAP Block after cesarean section.

Interventions

Intervention 1: Intervention group: In this group, after the completion of the cesarean section, we inject 0.25% bupivacaine into the patient using the TAP block method. Intervention 2: Intervention g

Sponsors

Yazd University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 35 Years

Inclusion criteria

Inclusion criteria: All women aged 20 to 35 years are candidates for non-emergency cesarean section with spinal anesthesia nulliparous multiparous ASA class l, ll

Exclusion criteria

Exclusion criteria: Patient's unwillingness to participate in the plan, preeclampsia, eclampsia severe cardiac failure Severe pulmonary failure Severe renal failure Severe hepatic failure contraindications to spinal anesthesia

Design outcomes

Primary

MeasureTime frame
The level of pain. Timepoint: 6-12-24. Method of measurement: visual analog scale (VAS).;Amount of narcotics needed in 24 hours. Timepoint: 6-12-24. Method of measurement: Asking the nurse and recording in the questionnaire.;Presence or absence of complications. Timepoint: 6-12-24. Method of measurement: Asking questions to the nurse and patient.;The time of the first drug request. Timepoint: 6-12-24. Method of measurement: Asking the nurse and recording in the questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Shekoufeh Behdad

Yazd University of Medical Sciences

drbehdad@ssu.ac.ir0098 35 8231932

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026